What factors are associated with recent prostate-specific antigen screening in transgender women?

A new study reports on factors associated with prostate cancer screening among transgender women.

Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Miscellaneous 05-Dec-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

December 6, 2023

CDMOs Nephron and Canton each raise hundreds of millions in financing

Nephron Pharmaceuticals and Canton Biologics recently announced capital raises totaling hundreds of millions of dollars, joining the growing market for contract and development manufacturing companies.

September 19, 2023

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO – Biotech Investments

PolyPeptide Group / Key word(s): Half Year Results 15-Aug-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.